Beachbody reported a net income of $6.95 million for the nine months ended September 30, 2026, a significant improvement from the $8.08 million net loss in the prior year period. Total revenue decreased from $196.2 million to $149.1 million year-over-year, but the company achieved profitability through substantial reductions in selling, marketing, and general administrative expenses.
SANUWAVE Health reported a net operating loss of $2.5 million for the nine months ended September 30, 2026, compared to an operating income of $2.9 million in the prior year period. Total revenue decreased to $27.9 million from $30.7 million, while operating expenses increased primarily due to higher research and development and selling costs.
KORU Medical Systems reported net revenues of $11.6 million for the quarter ended September 30, 2026, representing growth over the $10.4 million reported in the prior year period. The company achieved a net income of $0.2 million for the quarter, a significant improvement from the $0.8 million net loss in the same period of 2025.
Tandy Leather Factory reported third quarter 2026 revenues of $18.5 million, a 7.3% increase year-over-year, and returned to profitability with net income of $0.5 million. The company highlighted operational improvements and store expansions in Waco, Texas, and Charleston, South Carolina, as key drivers of the 181.9% increase in operating income.
Term
Q3 2026
“We are happy to have continued our growth from the first half of the year with another strong quarter. We saw growth in both retail and e-commerce channels and considerably increased our operating income. Following our new store opening in Waco, Texas in the second quarter, we continued our store expansion in the third quarter with a new opening in Charleston, South Carolina. During the third quarter, we continued to invest in our store fleet, our e-commerce channel and operations but our sales and margin growth more than offset these expenses, driving strong increases in profit from operations.”
KORU Medical Systems reported Q3 2026 net revenues of $11.6 million, an 11% increase year-over-year, and achieved its second consecutive quarter of positive net income. The company revised its full-year 2026 revenue guidance to $48.0-$48.5 million and highlighted growth in domestic core revenues driven by higher pump and consumable volumes.
Term
Q3 2026
“Total Revenue of $11.6 million represents another quarter of consistent above-market growth for KORU, driven by our recurring patient base. We also delivered positive net income and adjusted EBITDA for the second consecutive quarter, demonstrating the scalability of our business model.”
Angel Studios reported significant revenue growth for the nine months ended September 30, 2026, reaching $385.8 million compared to $211.6 million in the prior year. While the company remains net loss-making, it significantly narrowed its operating loss from $92.9 million to $31.5 million year-over-year, driven by improved operating leverage and a substantial increase in additional paid-in capital from common stock issuances.
Evolution Petroleum Corporation reported total assets of $180.5 million as of September 30, 2026, with oil and natural gas properties increasing to $158.5 million. The company utilized its senior secured credit facility, which had an outstanding balance of $60.0 million, to support its multi-basin portfolio and development activities. Management's strategy remains focused on maximizing cash flow to fund dividends and potential future acquisitions.
For the quarter ended September 30, 2026, iBio reported revenue of $1.075 million, a significant increase from $100,000 in the prior year. However, net loss widened to $7.551 million compared to $5.720 million in 2025, primarily driven by a nearly 90% increase in research and development expenses.
Inhibikase Therapeutics reported a significant increase in total assets to $201.8 million as of September 30, 2026, driven by a substantial rise in marketable securities. The company's accumulated deficit grew to $199.1 million, reflecting ongoing research and development investments, while common stock outstanding increased to 140,269,633 shares.
Evolution Petroleum reported fiscal first quarter 2027 results with revenue of $22.6 million, driven by higher realized oil and NGL prices. The company reported a net loss of $3.0 million but highlighted that its recently acquired Permian Minerals portfolio exceeded production expectations. Additionally, the board declared its 53rd consecutive quarterly cash dividend of $0.12 per share.
Term
Q1 2027
“We are encouraged by our fiscal first quarter results and excited about the outlook for our diversified portfolio, particularly the increasing contributions from our growing mineral and royalty interests.”
Kelly Loyd, President and Chief Executive Officer
“Our recently acquired Permian Minerals exceeded production expectations, and our late fiscal 2026 acquisitions of Haynesville and Bossier Shale minerals and royalties are contributing in line with expectations as new wells enter production.”
For the nine months ended September 30, 2026, North Haven Private Income Fund LLC reported total investment income of $446.7 million and net investment income of $199.4 million. The fund experienced a net decrease in members' capital of $433.0 million during the period, primarily driven by $476.9 million in unit repurchases and $159.9 million in net realized and unrealized losses.
For the nine months ended September 30, 2026, Fortress Private Lending Fund reported total investment income of $134.0 million and net investment income of $72.3 million. Total net assets grew to $1.14 billion, driven by $279.5 million in share issuances, despite a net realized loss of $26.3 million primarily from non-controlled investments.
iBio reported financial results for its first fiscal quarter of 2027, highlighting a revenue increase to $1.1 million compared to $0.1 million in the prior year. The company advanced its obesity pipeline, completing dosing in the SAD portion of its Phase 1 trial for IBIO-600 and presenting preclinical data for IBIO-610 showing improved fat-selective weight loss in combination with GLP-1 therapy.
Term
Q1 2027
“This was a quarter of focus and execution as we advanced our portfolio of long-acting antibody therapeutics designed to address important challenges in obesity care. The data presented at EASD strengthen our conviction in IBIO-610’s potential to deliver high-quality weight loss and provide important preclinical validation as we advance toward an IND-equivalent filing by the end of 2026, with plans to initiate first-in-human studies in the first half of 2027.”
Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer
Angel Studios reported Q3 2026 revenue of $159.0 million, a 107.7% year-over-year increase driven by the success of 'Young Washington' and growth in its Angel Guild membership to 2.94 million paying members. The company significantly reduced its net loss to $5.2 million and generated positive operating cash flow of $10.3 million. Management reiterated its full-year 2026 guidance for an Adjusted EBITDA loss of less than $25 million.
Term
Q3 2026
“Our model continues to show results, surpassing analyst expectations. Q3 revenue more than doubled year-over-year to $159 million, and we added approximately 335,000 net new members in the quarter to reach 2.94 million paying Guild members, while the rest of the US subscription video on demand (SVOD) industry lost 1.7 million subscribers, according to Antenna*.”
Neal Harmon, CEO
“The Angel team has more than doubled revenue in our first year as a publicly listed company. But we have greater ambitions than that. I am reminded of a quote from Cabrini, “The world is too small for what [we] intend to do.””
Datacentrex reported Q3 2026 financial results, achieving a positive Adjusted EBITDA of $1.3 million compared to a loss in the prior quarter. The company also highlighted a $30 million strategic investment in Eagle LNG to gain exposure to energy infrastructure and space propulsion markets. As of quarter-end, the company maintained $29.3 million in cash and digital assets with zero debt.
Counterparty
Eagle LNG
Term
Q3 2026
“Third-quarter Adjusted EBITDA was positive at approximately $1.3 million, including $2.2 million of net realized and unrealized gains on digital assets. We also maintained substantial liquidity following our $30 million investment in Eagle LNG, ending September with approximately $29.3 million in cash and digital assets, including $27.5 million in cash, and no outstanding debt.”
Parker Scott, Chief Executive Officer
“Our $30 million investment in Eagle LNG gives us an ownership position in an operating energy business with established infrastructure and customers under long-term supply agreements. As we approach 2027, we believe Eagle’s marine and Caribbean energy business provides a foundation for growth, while its ability to supply aerospace-specification liquid methane creates additional opportunity as the next generation of commercial launch vehicles enters service and scales.”
Corbus Pharmaceuticals reported a net loss of $95.8 million for the nine months ended September 30, 2026, driven by a significant increase in research and development expenses related to its ADC and obesity pipelines. The company's cash and investment position decreased to approximately $115.3 million from $163.3 million at the end of 2025, despite raising $27.6 million through common stock issuances.
Stran & Company reported Q3 2026 revenue of $28.1 million, an 8.2% increase year-over-year, and achieved a net income of $35,000 compared to a loss in the prior-year period. The company saw significant margin expansion to 33.3%, driven largely by its Stran Loyalty Solutions segment. For the first nine months of 2026, the company generated $1.1 million in net income and $1.8 million in positive operating cash flow.
Term
Q3 2026
“Our third-quarter results reflect the progress we are making in building a stronger, more profitable business. Revenue grew 8.2% to $28.1 million, gross profit increased 32.4% to $9.4 million, and gross margin expanded by approximately 610 basis points to 33.3%.”
Andy Shape, Chief Executive Officer of Stran
“Looking ahead, our focus remains on translating revenue growth into stronger earnings and cash flow, while maintaining the financial flexibility to pursue new customer opportunities and strategic growth initiatives.”
Big Sky Industrial Inc. reported a net loss of $9.0 million for the nine months ended September 30, 2026, compared to a $12.5 million loss in the prior year period. The company significantly increased its unproved industrial gas properties to $42.5 million and expanded its common stock outstanding to 52.5 million shares following an underwritten offering.
VineBrook Homes Trust, Inc. reported a significant increase in real estate held for sale, rising from $91.5 million at the end of 2025 to $239.9 million as of September 30, 2026, as part of a strategy to sell approximately 2,725 homes to satisfy upcoming debt obligations. The company's total net real estate investments decreased to $2.65 billion, and it faces new regulatory risks from the 21st Century ROAD to Housing Act enacted in July 2026.
Fortitude Gold reported third quarter 2026 net sales of $10.3 million and net income of $2.0 million, or $0.07 per share. The company produced 2,139 gold ounces during the period and maintained a cash balance of $8.5 million while continuing permitting efforts for its Golden Mile property.
Term
3 months
“We had a very busy and productive third quarter including the ongoing expansion of our heap leach pad.”
Alto Neuroscience reported a net loss of $79.0 million for the nine months ended September 30, 2026, compared to $47.1 million in the prior year, driven by a significant increase in research and development expenses. The company strengthened its balance sheet through a private placement and direct shelf offering, ending the period with $319.3 million in cash and cash equivalents.
West Coast Community Bancorp reported net income of $43.9 million for the nine months ended September 30, 2026, an increase from $36.7 million in the prior year period. Total assets grew to $2.98 billion, driven by a $164.5 million increase in loans held for investment, while the company successfully retired its subordinated debentures during the period.
Zion Oil & Gas reported a net loss of $5.9 million for the nine months ended September 30, 2026, compared to $5.3 million in the prior year period. The company remains in the exploration phase with $38.4 million invested in unproved oil and gas properties and continues to fund operations primarily through the sale of common stock and exercise of warrants, raising $17.3 million during the first nine months of 2026.
Waters Corp reported a significant increase in total net revenues to $1.77 billion for the third quarter of 2026, driven by the BDS Business Acquisition. However, the company recorded a net loss of $127 million for the first nine months of 2026, primarily due to higher interest expenses and substantial amortization of purchased intangibles following the acquisition.
Lake Shore Bancorp reported net income of $6.4 million for the nine months ended September 30, 2026, an increase from $5.3 million in the prior year period, driven primarily by higher net interest income. Total assets grew slightly to $734.2 million, while the company experienced a significant unrealized loss on securities available for sale, impacting accumulated other comprehensive loss.
ClearOne, Inc. reported zero revenue for the quarter ended September 30, 2026, following the sale of its operating assets in late 2025. The company recorded a net loss of $0.7 million for the quarter and is currently focused on fulfilling legacy obligations and pursuing a merger with Cortigent, Inc. and Vivani Medical, Inc. while facing potential Nasdaq delisting.
Datacentrex, Inc. reported a net loss of $14.2 million for the nine months ended September 30, 2026, compared to a $3.4 million loss in the prior year period, driven by significantly higher depreciation and stock-based compensation. Despite the net loss, the company increased its total assets to $72.9 million, bolstered by a $30 million investment in ELNG Equity LLC and proceeds from a public offering.
Kopin Corp reported total revenues of $18.2 million for the quarter ended September 26, 2026, a significant increase from $12.0 million in the prior year, driven by higher research and development revenues and grant income. Despite the revenue growth, the company realized a net loss of $3.4 million for the quarter, compared to a net income of $4.1 million in the same period in 2025.
Marathon Bancorp reported net income of $452,896 for the quarter ended September 30, 2026, a slight increase from $444,293 in the prior year period. Total assets decreased slightly to $258.9 million, while total deposits grew by approximately $11.3 million during the quarter, offset by a $15 million reduction in FHLB advances.
Urban One reported a net revenue decrease of 5.0% to $88.0 million for Q3 2026, driven by adverse market conditions in radio and weak demand in the Cable TV scatter market. The company reported a significant net loss of $119.2 million, primarily due to a $128.9 million impairment charge on goodwill and intangible assets. Management lowered its full-year 2026 Adjusted EBITDA guidance to $40.0 million and identified $20.0 million in annualized cost savings for the upcoming year.
Term
3 months
“Market conditions in radio continued to adversely impact revenue in the third quarter. We were helped by net political revenue of over $0.8 million in the quarter and the acquisition of stations in our Dallas market, effective July 17th, which contributed an additional $1.9 million of net revenue in the quarter.”
Alfred C. Liggins, III, Urban One’s CEO and President
“Revised Adjusted EBITDA guide for 2026 is now $40.0 million given the realities of the current advertising marketplace. Management is hyper-focused on cost reductions heading into next year and has identified at least $20.0 million of annualized savings.”
Alfred C. Liggins, III, Urban One’s CEO and President